Martin Huber
Corporate Officer/Principal bei NAUTILUS BIOTECHNOLOGY, INC.
Profil
Martin Huber is the founder of Quantapore, Inc. which was founded in 2009.
He held the title of Chief Executive Officer & Director.
Currently, he is the VP-Biochemistry & Flow Cell Development at Nautilus Biotechnology, Inc. where he started in 2023.
Dr. Huber has a graduate and doctorate degree from the University of Vienna.
Aktive Positionen von Martin Huber
| Unternehmen | Position | Beginn |
|---|---|---|
| NAUTILUS BIOTECHNOLOGY, INC. | Corporate Officer/Principal | 01.11.2023 |
Ehemalige bekannte Positionen von Martin Huber
| Unternehmen | Position | Ende |
|---|---|---|
Quantapore, Inc.
 Quantapore, Inc. BiotechnologyHealth Technology Quantapore, Inc. develops nanopore based nucleic acid sequencing technology products. The firm's proprietary DNA sequencing technology is based on an optically labeled nanopore which interacts via energy transfer with a labeled nucleic acid sample. The company was founded by Martin Huber and Sascha C. Dennstedt in 2009 and is headquartered in Menlo Park, CA. | Founder | - |
Ausbildung von Martin Huber
| University of Vienna | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NAUTILUS BIOTECHNOLOGY, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Quantapore, Inc.
Quantapore, Inc. BiotechnologyHealth Technology Quantapore, Inc. develops nanopore based nucleic acid sequencing technology products. The firm's proprietary DNA sequencing technology is based on an optically labeled nanopore which interacts via energy transfer with a labeled nucleic acid sample. The company was founded by Martin Huber and Sascha C. Dennstedt in 2009 and is headquartered in Menlo Park, CA. | Health Technology |
